Pulmonary Arterial Hypertension

We know that people with a rare disease, such as Pulmonary Arterial Hypertension (PAH), face very similar problems including:

• A delay in diagnosis and treatment due to limited awareness of their condition
• Difficulty accessing information, the best service and treatment, either because of locality or because one does not exist
• Difficulty navigating the health system and accessing support, whether this is in the form of equipment, financial or peer support

Lung Foundation Australia has a range of evidence-based services and resources that will enable your patients to better understand and manage their condition. Our services and resources are designed to support clinical treatment plans and help drive optimal health outcomes.  For more information or hard copies of resources, please contact us.